The association between the rs11196218A/G polymorphism of the TCF7L2 gene and type 2 diabetes in the Chinese Han population: a meta-analysis

被引:6
作者
Ma, Enting [1 ]
Wang, Huili [2 ]
Guo, Jing [1 ]
Tian, Ruirui [3 ]
Wei, Li [4 ]
机构
[1] Tianjin Med Univ, Gen Hosp, Dept Pediat Ward, Tianjin, Peoples R China
[2] Xian Int Univ, Dept Nursing, Xian, Peoples R China
[3] Tianjin Med Univ, Dept Nursing, Tianjin, Peoples R China
[4] Tianjin Med Univ, Gen Hosp, Dept Surg, Tianjin, Peoples R China
关键词
Type 2 diabetes mellitus (T2DM); Transcription factor 7-like 2 (TCF7L2); rs11196218A/G polymorphism; Meta-analysis; SUSCEPTIBILITY GENES; VARIANTS; RISK; REPLICATION; MELLITUS; EXPRESSION;
D O I
10.6061/clinics/2015(08)10
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Transcription factor 7-like 2 has been shown to be associated with type 2 diabetes mellitus in multiple ethnic groups in recent years. In the Chinese Han population in particular, numerous studies have evaluated the association between the rs11196218A/G polymorphism of the transcription factor 7-like 2 gene and type 2 diabetes mellitus. However, the results have been inconsistent, so we performed a meta-analysis to assess the association. Odds ratio and 95% confidence interval values were calculated using a random-effects model or a fixed-effects model based on heterogeneity analysis. The quality of the included studies was evaluated using the Newcastle-Ottawa Scale. Subgroup analyses were conducted based on conformity with Hardy-Weinberg equilibrium in the control group as well as on other variables, such as age, sex and body mass index. Sensitivity analysis was also performed to detect heterogeneity and to assess the stability of the results. In total, 10 case-control studies comprising 7,491 cases and 12,968 controls were included in this meta-analysis. The combined analysis indicated that the rs11196218A/G polymorphism was not associated with type 2 diabetes mellitus (G vs. A, OR=1.04, 95% CI=0.97-1.13, p=0.28). The subgroup analyses also did not show any association between the rs11196218A/G polymorphism and the risk of type 2 diabetes mellitus. Furthermore, the results of the subgroup analyses indicated that the absence of an association was not influenced by age, sex or body mass index. The results of the sensitivity analysis verified the reliability and stability of this meta-analysis. In conclusion, this study indicated that there is no significant association between the rs11196218A/G polymorphism and the risk of type 2 diabetes mellitus in the Chinese Han population.
引用
收藏
页码:593 / 599
页数:7
相关论文
共 41 条
[1]  
[Anonymous], The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomized Studies in Meta- Analysis
[2]  
[Anonymous], 2009, THESIS
[3]  
[Anonymous], GENETIKA
[4]  
[Anonymous], 2019, THESIS DALIAN U TECH
[5]  
[Anonymous], THESIS
[6]   Transcription factor TCF7L2 genetic study in the French population -: Expression in human β-cells and adipose tissue and strong association with type 2 diabetes [J].
Cauchi, Stephane ;
Meyre, David ;
Dina, Christian ;
Choquet, Helene ;
Samson, Chantal ;
Gallina, Sophie ;
Balkau, Beverley ;
Charpentier, Guillaume ;
Pattou, Francois ;
Stetsyuk, Volodymyr ;
Scharfmann, Raphael ;
Staels, Bart ;
Fruhbeck, Gema ;
Froguel, Philippe .
DIABETES, 2006, 55 (10) :2903-2908
[7]   Common variants in the TCF7L2 gene are strongly associated with type 2 diabetes mellitus in the Indian population [J].
Chandak, G. R. ;
Janipalli, C. S. ;
Bhaskar, S. ;
Kulkarni, S. R. ;
Mohankrishna, P. ;
Hattersley, A. T. ;
Frayling, T. M. ;
Yajnik, C. S. .
DIABETOLOGIA, 2007, 50 (01) :63-67
[8]   METAANALYSIS IN CLINICAL-TRIALS [J].
DERSIMONIAN, R ;
LAIRD, N .
CONTROLLED CLINICAL TRIALS, 1986, 7 (03) :177-188
[9]   Assignment of the TCF-4 gene (TCF7L2) to human chromosome band 10q25.3 [J].
Duval, A ;
Busson-Leconiat, M ;
Berger, R ;
Hamelin, R .
CYTOGENETICS AND CELL GENETICS, 2000, 88 (3-4) :264-265
[10]   Type 2 Diabetes Susceptibility Gene TCF7L2 and Its Role in β-Cell Function [J].
Gloyn, Anna L. ;
Braun, Matthias ;
Rorsman, Patrik .
DIABETES, 2009, 58 (04) :800-802